Optical Coherence Tomography Angiography Compared to Maternal Doppler in Screening for Hypertension in Pregnancy
Retinal Microvascular Changes by Optical Coherence Tomography Angiography Compared to Maternal Uterine Artry Doppler in Screening for Hypertensive Disorders in High-risk Pregnancies
1 other identifier
observational
60
1 country
1
Brief Summary
Pregnancy related hypertension is one of the most prevalent obstetric complications. The aim of the study is to evaluate the validity and sensitivity of OCT angiography in prediction of pregnancy induced hypertensive disorders in comparison to maternal doppler in the first and second trimesters of pregnancy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
April 8, 2022
CompletedFirst Posted
Study publicly available on registry
April 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedApril 15, 2022
April 1, 2022
8 months
April 8, 2022
April 8, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
validity and sensitivity of OCT angiography
sensitivity of OCTA in comparison to doppler in prediction of pregnancy related hypertension
6 months
Study Arms (2)
case group
control
Interventions
vascular changes in retina by OCT angiography and uterine artry doppler in the first and second trimesters
Eligibility Criteria
two groups according to the risk of developing hypertension during pregnancy
You may qualify if:
- Pregnant women in the first and second trimesters
You may not qualify if:
- pregnant females with associated systemic vascular disease as diabetes, SLE
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia University
Minya, Minia Governorate, 61111, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of Ophthalmology
Study Record Dates
First Submitted
April 8, 2022
First Posted
April 15, 2022
Study Start
April 1, 2022
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
April 15, 2022
Record last verified: 2022-04